clag regimen Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Any (1)

Unknown (1)

Interventional (1)

Zhejiang University (1)

No (1)

No (1)

Adult (18+) (1)

affili (1)
first (1)
hospit (1)
medicin (1)
school (1)
univers (1)
zhejiang (1)

I am/have/had

I am/have/hadremission

I am/have/hadacute promyelocytic leukemia

I am/have/hadejection fraction

I am/have/hadblast cells

I am/have/hadgranulocyte colony stimulating factor

I am/have/hadglomerular filtration rate

I am/have/hadmyeloid leukemia

I am/have/hadleukemia

I am/have/hadclag regimen

I am/have/hadnephropathy

I am/have/hadrefractory acute myeloid leukemia (aml)

I am/have/hadcancer

I am/have/hadacute leukemia

added new label for I am/have/had

more

I am looking for

I am looking forcolony stimulating factor

I am looking foridarubicin

I am looking forcladribine

I am looking forcytarabine

I am looking forgranulocyte colony stimulating factor

I am looking fordecitabine

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

A prospective, single-arm, multicenter, exploratory study to evaluate the efficacy and safety of D-CLAG regimen in the treatment of relapsed or refractory acute myeloid leukemia

acute promyelocytic leukemia

cladribine

ejection fraction

cytarabine

glomerular filtration rate

0 views
17 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.